Sotera Health Co (SHC) company profile
Close on Nov 17, 2026Market cap $4.58BP/E 28.2Yield –
About Sotera Health
Services-Misc Health & Allied Services, NEC, SIC 8090
The company provides outsourced terminal sterilization solutions, microbiological and analytical lab testing, and technical advisory services. It operates primarily through two segments: Sterilization Services (comprising Sterigenics and Nordion) and Lab Testing and Advisory Services (Nelson Labs). Sterigenics delivers terminal sterilization using gamma irradiation, ethylene oxide processing, and electron-beam irradiation. Nordion supplies Cobalt-60 radiation sources and manufactures gamma irradiation units for industrial sterilization and oncology applications. Nelson Labs conducts testing across healthcare product life cycles, including sterility assurance, biocompatibility, and regulatory compliance consulting. The company primarily serves medical device and pharmaceutical manufacturers, alongside food safety and advanced commercial customers.
Operations encompass a network of 62 facilities worldwide, including 48 sterilization facilities located across 13 countries as well as specialized laboratories and processing centers in North America and Europe. The enterprise supports customers in over 50 countries and employs more than 3,000 workers globally. Its headquarters is not stated in the provided text.
Summary of the business section of Sotera Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Sotera Health Co
- Headquarters
- Broadview Heights, OH
- Address
- 9100 South Hills Blvd, Suite 300 44147
- Phone
- (440) 262-1410
- Website
- soterahealth.com
- Employees
- 3,000, Dec 31, 2025
- Industry
- Services-Misc Health & Allied Services, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, Cleveland, Ohio
Stock & identifiers
- Ticker
- SHC
- Exchange
- Nasdaq
- IPO date
- Nov 23, 2020
- Shares outstanding
- 285M, Jul 30, 2026
- Public float
- $1.71B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1822479
- CUSIP
- 83601L102
- ISIN
- US83601L1026
- FIGI
- BBG008LZG0Z5
- Share class FIGI
- BBG008LZG101
- EIN
- 47-3531161
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Michael B. Petras Jr. | Executive Chairman, Director | 4,367,305 |
| Alton Shader | Chief Executive Officer, Director | 579,573 |
| Michael P. Rutz | President of Sterigenics | 334,279 |
| Jonathan M. Lyons | Sr. Vice President, CFO | 217,304 |
| Erika Ostrowski | SVP, General Counsel and Sec. | 57,538 |
| Alexander Dimitrief | Former SVP, GC and Sec. | 312,040 |
| Kenneth D. Krause | Director | 14,970 |
| David E. Wheadon | Director | 89,882 |
| Richard G. Kyle | Director | 14,970 |
| Vincent K. Petrella | Director | 95,751 |
| James Neary | Director | 95,751 |
| Karen Flynn | Director | 54,191 |
| Simon, Christopher | Director | 34,102 |
| Ann R. Klee | Director | 140,926 |
| Sean Laurence Cunningham | Director | 95,751 |
| Ruoxi Chen | Director | 95,751 |
| Pincus (Bermuda) Private Equity GP Ltd. Warburg | Director | 118,929,897 |
| Co-Invest Xi Lp Gtcr | Director | 12,735,301 |
| Investment Xi Llc Gtcr | Director | 41,215,301 |
| Partners Xi/A&c Lp Gtcr | Director | 49,215,301 |
| Fund Xi/C Lp Gtcr | Director | 0 |
| Warburg Pincus Partners II (Cayman), L.P. | Director | – |
| Holdco L.P. Bull | Director | 73,822,952 |
| Pincus Llc Warburg | Director | 34,102,952 |
| Pincus & Co. Warburg | Director | 61,822,952 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $10.66M | $16.71M | $2.58M | $64 | $148 |
| FY2024 | $10.39M | $5.07M | $2.34M | $54 | $136 |
| FY2023 | $9.70M | $31.19M | $1.41M | $67 | $132 |
| FY2022 | $16.66M | $5.91M | $2.00M | $33 | $130 |
| FY2021 | $2.20M | -$2.36M | $658.89K | $94 | $132 |
| FY2020 | $17.20M | $22.42M | $5.01M | $109 | $105 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| Michael B. Petras, Jr. Chairman and CEO | $1.13M | – | $8.02M | $1.48M | $18.07K | $10.66M | +3% |
| Jonathan Lyons SVP, CFO | $536.54K | $50.00K | $2.09M | $394.58K | $17.99K | $3.09M | +44% |
| Michael P. Rutz President of Sterigenics | $500.00K | – | $1.34M | $320.25K | $18.51K | $2.18M | -12% |
| Alexander Dimitrief Former SVP and General Counsel | $600.00K | – | $1.55M | $309.00K | $2.99K | $2.46M | +3% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Nov 23, 2020
- Offer price
- $23.00
- Securities offered
- 46,600,000
- Gross proceeds
- $1.07B
- Exchange
- Nasdaq
- First trading day
- Nov 20, 2020
- First-day close
- $25.10+9.1%
- Lock-up ends (est.)
- May 19, 2021
“The initial public offering price of the common stock is $23.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed over 3,000 employees worldwide.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Nov 23, 2020 | IPO | Initial public offering priced (424B4 prospectus) |
| Nov 20, 2020 | Listing | Registration of securities on an exchange (Form 8-A) |
| Oct 9, 2020 | Name change | Name changed from Sotera Health Topco, Inc. to Sotera Health Co |
See a number that looks wrong?